ABSCI CORP Marketable Securities (Current)
ABSCI CORP (ABSI) had Marketable Securities (Current) of $93.28 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-11
- 2026-06-30: Marketable Securities, Current $93.28M.
- 2026-03-31: Marketable Securities, Current $117.08M.
- 2025-12-31: Marketable Securities, Current $124.27M.
- 2025-09-30: Marketable Securities, Current $143.00M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $93.28M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $117.08M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $124.27M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $143.00M 10-Q · filed 2025-11-12 |
| 2024-12-31 | $71.21M 10-K · filed 2026-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |